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ABSTRACT For over a century, a fundamental objective in infection biology research has been to understand the molecular pro-
cesses contributing to the origin and perpetuation of epidemics. Divergent hypotheses have emerged concerning the extent to
which environmental events or pathogen evolution dominates in these processes. Remarkably few studies bear on this important
issue. Based on population pathogenomic analysis of 1,200 Streptococcus pyogenes type emm89 infection isolates, we report that
a series of horizontal gene transfer events produced a new pathogenic genotype with increased ability to cause infection, leading
to an epidemic wave of disease on at least two continents. In the aggregate, these and other genetic changes substantially remod-
eled the transcriptomes of the evolved progeny, causing extensive differential expression of virulence genes and altered
pathogen-host interaction, including enhanced immune evasion. Our findings delineate the precise molecular genetic changes
that occurred and enhance our understanding of the evolutionary processes that contribute to the emergence and persistence of
epidemically successful pathogen clones. The data have significant implications for understanding bacterial epidemics and for
translational research efforts to blunt their detrimental effects.
IMPORTANCE The confluence of studies of molecular events underlying pathogen strain emergence, evolutionary genetic pro-
cesses mediating altered virulence, and epidemics is in its infancy. Although understanding these events is necessary to develop
new or improved strategies to protect health, surprisingly few studies have addressed this issue, in particular, at the comprehen-
sive population genomic level. Herein we establish that substantial remodeling of the transcriptome of the human-specific
pathogen Streptococcus pyogenes by horizontal gene flow and other evolutionary genetic changes is a central factor in precipitat-
ing and perpetuating epidemic disease. The data unambiguously show that the key outcome of these molecular events is evolu-
tion of a new, more virulent pathogenic genotype. Our findings provide new understanding of epidemic disease.
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Genetic diversity begets phenotype variation and with it thepossibility of a different life. Considerable effort has been
expended in the last 40 years to understand the genetic diversity
and population structure of many bacterial pathogens, especially
those that detrimentally affect human and livestock health and
cause epidemics (1–27). These studies have led to the general con-
cept that some bacterial species are clonal, with relatively little
evidence that horizontal gene transfer (HGT) and recombination
shape species diversity, whereas other bacterial pathogens are
highly recombinogenic, with species diversity mediated by exten-
sive HGT events (1–27). Genetic studies have been greatly facili-
tated in recent years by relatively inexpensive large-scale compar-
ative DNA sequencing, which now makes it possible to precisely
delineate the nature and extent of genomic variation present in
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large populations (hundreds to many thousands) of individual
pathogenic bacterial species (4, 5, 10–18, 23–26). For example,
analyses of important pathogens such as Staphylococcus aureus,
Streptococcus pyogenes, Streptococcus pneumoniae, Escherichia coli,
Salmonella enterica serovars, and Legionella pneumophila have
been conducted, resulting in much new information about genetic
variation in these and other species (4, 5, 10–18, 23–26, 28–35).
In parallel with studies of bacterial population genetic struc-
ture, there has been interest in identifying the precise genomic
changes that contribute to the emergence, numerical success, and
epidemic behavior of members of some bacterial species. A major
effort has been devoted to analysis of comprehensive, population-
based samples of the strict human pathogen S. pyogenes (com-
monly, group A streptococcus [GAS]) as a model pathogen (28–
35). S. pyogenes is endemic in humans worldwide and periodically
causes epidemics of superficial (e.g., pharyngitis and impetigo)
and invasive (e.g., necrotizing fasciitis, pneumonia, myositis) in-
fections. Globally, the organism causes an estimated 711 million
human infections and over 500,000 deaths annually (36). The spe-
cies is genetically diverse, with more than 240 emm-types (typing
based on sequence differences in the hypervariable amino-
terminal portion of the emm gene encoding the antiphagocytic
Emm virulence protein; http://www.cdc.gov/abcs/index.html),
and approximately 650 multilocus sequence types (MLSTs)
(http://spyogenes.mlst.net) described.
In the early 1980s, a dramatic increase in the frequency and
severity of infections caused by S. pyogenes led to the recognition
of a global pandemic caused by emm1 strains (37–44). This pan-
demic afforded the opportunity to compare preepidemic and ep-
idemic strains for potential bacterial factors contributing to this
global health problem. To gain insight into the emergence, dis-
semination, and diversification of emm1 strains causing this pan-
demic, we sequenced the genome of 3,615 emm1 infection isolates
(32). Phylogenetic analyses revealed that the pandemic emm1
strains that emerged are a genetically closely related clonal popu-
lation that evolved from its most recent preepidemic progenitor in
the early 1980s. The key genetic event underpinning the pandemic
was acquisition by HGT and recombinational replacement of a 36
kb segment of the S. pyogenes core chromosome (i.e., that portion
of the chromosome/genome that is largely conserved across emm-
types and not present on obvious mobile genetic elements such as
phages and integrative-conjugative elements) that mediated en-
hanced production of toxins NAD glycohydrolase (SPN [S. pyo-
genes NADase]) and streptolysin O (SLO) (32). A subsequent
study (35) showed that the striking upregulation of SPN and SLO
production and altered virulence phenotype by members of the
pandemic clone occurred as a consequence of only three single
nucleotide polymorphisms (SNPs). Two are located in the 35
to 10 spacer region of the promoter sequence upstream of the
nga-ifs-slo transcriptional unit and resulted in increased gene ex-
pression. The third, a nonsynonymous SNP in the nga gene, in-
creases the activity of SPN, a secreted cytotoxin virulence factor
(45). Additional evidence supporting the notion of upregulation
of SPN and SLO as a contributing cause of S. pyogenes epidemic
disease was found by sequence analysis of 1,125 emm89 genomes
(35) obtained in comprehensive population-based surveillance
studies conducted in the United States, Finland, and Iceland be-
tween 1995 and 2013. Among these emm89 strains, we identified
three distinct phylogenetic clades (designated clade 1, clade 2, and
clade 3). The current worldwide recent increase in the incidence of
emm89 invasive infections corresponded temporally with the
emergence and expansion of clade 3 strains upregulated in SPN
and SLO production (35, 46).
Thus, progress is being made in understanding genomic alter-
ations that are linked with increases in disease frequency and
severity in some human pathogens. However, despite these
advances, very little analogous work has been conducted to inves-
tigate global changes in gene expression that may contribute to the
origin and perpetuation of bacterial epidemics. Similarly, there is
a general lack of studies linking genome variation, transcriptional
changes, and altered virulence in epidemic forms. The primary
goal of this investigation was to study how genome variation
linked with changes in transcriptome and altered virulence might
contribute to the origin and perpetuation of bacterial epidemics,
using the ongoing S. pyogenes emm89 epidemic as a convenient
model system. We used comparative pathogenomics to dissect the
precise molecular genetic events that have mediated the evolu-
tionary origin and diversification of the epidemic emm89 strains.
Unexpectedly, we found that a high frequency of HGT events has
shaped the emm89 population genetic structure to a far greater
extent than vertically inherited SNPs and short insertions and de-
letions (indels). Three main mechanisms that mediate HGT in
bacteria have been described: conjugation, transduction, and
transformation. Although S. pyogenes is not considered to be nat-
urally competent, analysis of MLST data found S. pyogenes to have
a level of recombination comparable to that of Streptococcus pneu-
moniae, a species that is naturally competent (47). The mechanism
mediating the relatively high level of recombination detected in
GAS is not known, but, given the prevalence of phage in GAS
genomes, generalized transduction may play an important role.
Global transcriptome sequencing (RNAseq) analysis was con-
ducted on genetically representative preepidemic and epidemic
emm89 strains to determine the extent to which the genomic
changes causing altered gene expression may have contributed to
the epidemic. We found that HGT is extensive in the emm89 pop-
ulation and has contributed disproportionately to the diversifica-
tion of virulence factors and their expression. Nonsynonymous
SNPs in major regulatory genes and other modest genetic changes
have also led to transcriptome remodeling intimately linked with
the origination and perpetuation of the epidemic. The results have
significant implications for understanding epidemic bacterial dis-
ease and for translational research efforts designed to control or
limit the detrimental effect of infectious agents. The overall strat-
egy used as described here is of general utility and pertinence to the
investigation of other pathogens.
RESULTS AND DISCUSSION
Population genetic structure and contribution of horizontal
gene transfer (HGT).We studied 1,200 emm89 S. pyogenes strains,
virtually all (n  1,198) cultured from patients with invasive in-
fections that occurred between 1995 and 2014 (Fig. 1; see also
Table S1 in the supplemental material). The great majority of
strains (n  1,180) were collected as part of comprehensive
population-based studies conducted in the United States, Finland,
and Iceland. The genomes of all 1,200 strains were sequenced to a
mean 60-fold depth of coverage (range, 13-fold to 440-fold) using
an Illumina paired-end strategy, and polymorphisms were iden-
tified. Inference of genetic relationships using core chromosomal
SNPs revealed that these emm89 strains have a major population
of 1,193 strains and a minor population of 7 substantially diver-
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gent genetic outlier strains (Fig. 2A). Bayesian clustering showed
the major emm89 population of 1,193 strains to comprise 3 pri-
mary clades (Fig. 2B). The genomes of 3 strains representing the
genetic backgrounds of organisms assigned to the three primary
clades (MGAS11027 of clade 1, MGAS23530 of clade 2, and
MGAS27061 of clade 3) were closed and annotated (see Fig. S1).
The epidemiological information available for the 1,200 strains
revealed that clade 3 strains emerged and expanded rapidly in the
United States, Finland, and Iceland, displacing the corresponding
predecessor clade 1 and 2 strains in the populations studied
(Fig. 1). These findings are consistent with the preliminary data
that we recently reported (35).
The emm89 population genomic data revealed an unprece-
dented level of genetic diversity for strains of a single S. pyogenes
emm-type. Comparison of the emm89 genome sequences with
data available for 37 S. pyogenes genomes of 18 other emm-types
(see Table S2 in the supplemental material) showed that the
emm89 strains are the only emm-type to have two deeply rooted
branches in the phylogenetic network (Fig. 3). Although we found
evidence of recombination within the emm89 population, the ran-
dom distribution of SNPs and the lack of sequence identity of the
7 minor population emm89 outlier strains with sequences of an-
other GAS emm-type or MLST argue that these strains have not
arisen through emm-type switching.
We identified extensive genomic diversity between and within
the three primary emm89 clades. The mean genetic distance
(MGD) among the 1,193 strains of the 3 clades was 610 SNPs in
the core genome (Fig. 2B). In striking contrast, among 3,615
emm1 strains collected in 8 countries on two continents over
45 years (i.e., a collection 3 times larger, from a broader geo-
graphic region, and a period 2.5 times longer than those used for
analysis of the emm89 sample), the MGD was only 106 core SNPs
(32).
There was a nonrandom distribution of SNPs throughout the
emm89 core genomes. Multiple regions had elevated SNP density,
indicating HGT and core genomes with a mosaic evolutionary
history (Fig. 4; see also Fig. S1 in the supplemental material). Gub-
bins (genealogies unbiased by recombinations in nucleotide se-
quences) statistical analysis of SNP distribution (48) identified
2,316 regions of putative HGT with a mean size of 3,695 bp (range,
4 bp to 71,774 bp) at 526 loci around the genome. Because HGT
can distort inferences of genetic relationships and evolutionary
history, the phylogeny of the strains was reassessed using se-
quences filtered to exclude regions of recombination (Fig. 2C).
This analysis greatly reduced the MGD (i.e., average pairwise core
SNPs) among the 1,193 strains by 78% (from 610 to 134), a level
similar to that found in 3,615 emm1 strains (32). The MGD from
clade 1 to clade 2 and the MGD from clade 2 to clade 3 were
reduced by 87% and 76%, respectively. The MGD between strains
within each of the clades also was substantially reduced. The MGD
strain-to-strain within clade 1 went from 226 to 100 (56%),
within clade 2 from 83 to 63 (24%), and within clade 3 from 244
to 45 (82%). Importantly, however, after exclusion of SNPs
present in chromosomal segments associated with HGT events, 3
primary clades still remained among the 1,193 strains.
Outgroup rooting with the genome of emm1 reference strain
SF370 showed that the evolutionary pathway leading to the cur-
rent emm89 epidemic lineage had clades branching in the se-
quence of clade 1 followed by clade 2 and then clade 3 (see Fig. S2
in the supplemental material). Clade 1 and clade 2 strains differed
by 8 regions of HGT encompassing 171.1 kb or 10% of the ge-
nome, and clade 2 and clade 3 strains differed by 6 regions of HGT
encompassing 15.3 kb or 0.9% of the genome (Fig. 4 and Table 1).
Seven of the 8 HGT regions differentiating clade 1 and clade 2 are
most similar in sequence to regions in emm2 reference genome
MGAS10270 (see Fig. S3). Of special note, 33 isolates in clade 3
differed from the 725 other clade 3 strains by one additional HGT.
These strains, designated subclade 3D (SC-3D) (Fig. 2B), first oc-
curred in the Finland sample in 2009 and have disproportionately
increased in prevalence in recent years as a cause of bloodstream
infections in that country (see Table S1 and Fig. S4).
HGT events are responsible for the bulk of the core sequence
differences between the clades. The transferred sequences encom-
pass multiple genes encoding many known secreted and cell
surface-associated virulence factors, including the pilus/T-
antigen adhesin, fibronectin-binding protein FbaB, the toxin pair
NGA and SLO, internalin InlA, C5a peptidase ScpA, antiphago-
cytic M-like proteins Enn and Mrp, virulence regulators Mga and
Ihk-Irr, immunogenic secreted protein Isp1, and the HasABC
capsule synthesis enzymes (49). These HGT events have had im-
portant consequences. For example, clade 1 strains differ from
clade 2 and 3 strains in pilus/T-antigen, and the clade 3 strains
cannot produce capsule due to loss of the hasABC genes. Of note,
different pilus types have been shown to vary in cell adherence and
tissue tropism, and differences in the levels of production of cap-
sule and SPN and SLO cytotoxins can alter virulence (35, 49, 50).
Consistent with SPN and SLO playing a key role in S. pyogenes
strain emergence and enhanced fitness, each of the three clades has
a distinct nga-ifs-slo region resulting from two independent HGT
events. In addition, SC-3D strains differ from the other clade 3
strains due to HGT of a region encoding the SpyA and SpeJ viru-
lence factors (49, 51–53). Inasmuch as these multiple HGT events
involve regions encoding virulence factors, it is reasonable to hy-
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FIG 1 Temporal and geographic distribution of the emm89 strain cohort.
Shown is the temporal distribution of the emm89 strains by clade. The inset
shows the geographic distribution of the isolates by country. The colored hor-
izontal bars at the bottom of the figure show the temporal distribution of the
strains by country. A single isolate from Italy is not illustrated. The reduced
numbers of cases in 2014 are due to United States isolates not being available
for study rather than to a decline in the frequency of infections. Clade 3 strains
emerged in 2003 and expanded greatly in number, displacing the predecessor
clade 1 and 2 strain samples studied in all 3 populations (United States, Fin-
land, and Iceland).
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pothesize that many of these HGT events alter host-pathogen in-
teractions.
Variation in gene content and phage genotype. HGT in bac-
teria can be mediated by mobile genetic elements (MGE), phages,
and integrative-conjugative elements (ICEs). S. pyogenes phages
commonly encode one or more secreted virulence factors such as
streptococcal pyrogenic exotoxin superantigens and streptococcal
phage DNases (54, 55). S. pyogenes ICEs usually encode one or
more factors mediating resistance to antibiotics such as tetracy-
cline and macrolides (54). Horizontal acquisition of antibiotic
resistance and novel virulence factor genes, mediated by ICEs and
phages, has been associated with localized outbreaks and large
epidemics of S. pyogenes infections (29). MGE content was inves-
tigated in 1,193 emm89 isolates relative to the combined gene
content (53,000 genes) of 30 GAS genomes of 18 emm-types (see
Tables S1 and S2 in the supplemental material). This analysis
identified 64 different profiles of MGE content (Fig. 5). ICEs were
infrequent in the strain sample. The three most prevalent MGE
content profiles, or phage genotypes (PGs), accounted for 72% of
the strains (Fig. 5). These three phage genotypes (PG01, PG02,
and PG03) correspond to the phage content of the reference ge-
nomes for each of the three primary clades (Fig. S1 in the supple-
mental material). With the exception of PG02 (defined as lack of
prophages), most phage genotypes were confined to a single clade.
The most prevalent (43%) PG in clade 1 was PG03 (phage 11027.1
encoding SpeC and Spd1 and phage 11027.2 encoding Sdn). Also
prevalent were PG05 (13%) and PG06 (11%) strains, potentially
derived from PG03 strains by phage loss. Most clade 2 strains are
MGAS23530
MGAS11027 C1-to-C2 MGD = 220.8
C2-to-C3 MGD = 89.3
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FIG 2 Genetic relationships among emm89 strains. Genetic relationships were inferred by the neighbor-joining method based on concatenated core chromo-
somal SNP data using SplitsTree. (A) Genetic relationships based on 28,425 SNPs identified among the members of the entire population of 1,200 emm89 strains.
(B) Genetic relationships based on 11,846 SNPs identified among the 1,193 major population strains. Isolates are colored by cluster as determined using Bayesian
analysis of population structure (BAPS) as indicated in the hierarchy below the figure. Three major clades (C1, C2, and C3) are defined at the first level of
clustering. Subclade 3D (SC3D), a recently emerged and expanding population of strains in Finland, is defined at the second level of clustering. Indicated for the
inferred phylogenies are the mean genetic distances (MGDs), both inter- and intraclade, measured as differences in core chromosomal SNPs. The mean genetic
distance among strains within clades is less than the MGD to strains of the nearest neighboring clade(s). Bootstrap analysis with 100 iterations gives 100%
confidence for all of the clade-to-clade branches (i.e., C1-C2, C2-C3, and C3-SC3D). (C) Genetic relationships based on 8,989 SNPs identified among the major
population of 1,193 strains, filtered to exclude horizontally acquired sites as inferred using Gubbins. Exclusion of sites attributed to horizontal gene transfer
events collapses the MGD strain-to-strain both within and between the clades. The MGD within the clades remains less than the MGD to the nearest neighboring
clade(s). Trees in panels B and C are illustrated at the same scale.
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PG02 (72%), having no phages. The abundance of PG02 strains
representing 20% of the entire emm89 cohort is unusual in that,
prior to our investigation, nearly all S. pyogenes genomes had been
found to be polylysogenic (55). Most clade 3 strains are PG01
(62%), having phage 27061.1 encoding SpeC and Spd1, followed
next in prevalence by PG02 (22%). Of note, although phages
11027.1 and 27061.1 are integrated at the same genomic locus and
encode the same two secreted virulence factors, they are different
phages (see Fig. S5). PG01 (presence of 27061.1) first occurred in
our strain samples in 2003, a time that corresponds to the emer-
gence of the epidemic clade 3 strains. However, the acquisition of
27061.1 by the emm89 population does not result in the epidemic
clade 3 strains acquiring new phage-encoded virulence genes that
were not already prevalent in the preepidemic clade 1 strains. This
finding suggests that acquisition of phage-encoded virulence
genes was not a key driver for the emergence of epidemic clade 3
organisms as has been speculated (46).
HGT and extensively remodeled global transcriptomes. One
school of thought postulates that HGT events are similar to point
mutations in that most of them are neutral, or nearly so, and have
little effect on pathogen traits. The unexpected magnitude of HGT
events in the study population (based on previous findings from
analysis of other S. pyogenes emm-types) provided a unique op-
portunity to test the hypothesis that these HGT events have en-
hanced the virulence of the epidemic emm89 strains by remodel-
ing of the global transcriptome. As a consequence of the greater
technical difficulty and expense involved, global transcriptional
variation has been far less studied than genomic variation in bac-
terial pathogens. Moreover, since the data corresponding to the
groups of samples studied here were population based and com-
prehensive and included temporal-spatial information, we had
the additional opportunity to assess the potential effect of tran-
scriptome remodeling on strain emergence and dissemination.
We used RNAseq to compare transcript variations at two growth
points among genetically representative strains of clades 1, 2, and
3 (Fig. 6). These strains have the allelic variant of the major viru-
lence regulators covRS, mga, and ropB that is most common to the
clades they represent. These regulators lack known function-
altering polymorphisms that influence S. pyogenes gene expres-
sion and virulence (49, 56–60). The number of genes differentially
expressed in stationary-phase growth exceeded the number in
exponential-phase growth by approximately 3-fold in all of the
clade-to-clade comparisons (Fig. 7A). A general finding was that
the greater the genetic distance between strains was, the greater the
number of genes significantly altered in transcription. The largest
number of differentially expressed genes was recorded between
strains MGAS11027 (clade 1) and MGAS23530 (clade 2), consis-
tent with strains in these clades being separated by the greatest
MGD (Fig. 2). Genes altered in transcript level by 1.5-fold or
greater accounted for 14% and 36% of the genome at the expo-
nential and stationary growth phases, respectively, in comparisons
of MGAS11027 (clade 1) and MGAS23530 (clade 2) (see Table S3,
0.01
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FIG 3 Genetic relationships between strains of various Emm/M protein serotypes. Genetic relationships were inferred among 49 GAS strains of 20 M types based
on 75,184 concatenated core chromosomal SNPs by the neighbor network method. The analysis is based on 42 closed genomes and 7 whole-genome-sequenced
emm89 genetic outlier strains (indicated in italics). The MGD interserotype consists of 16,340 SNPs. emm89 strains are the only emm-type strains with two
distinct lineages (L1 and L2) in the interserotype network. The MGD of 14,247 SNPs between the emm89 L1 and L2 genomes is greater than the MGD of 11,548
SNPs among the serotype M5, M6, M18, and M23 genomes. Of note, the emm89 L1 to L2 MGD is greater than the emm89 L1 to M53 genome MGD of 14,194
SNPs.
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section 1, in the supplemental material). Although genes (n 
182) located within the eight distinct regions of HGT differentiat-
ing clade 1 and clade 2 comprise only 11% of the gene content,
they accounted for 24% of the differentially expressed genes at
exponential growth, a highly nonrandom occurrence (P 
0.0001). Importantly, genes encoding many key virulence factors
had significantly different transcript levels, including the
fibronectin/collagen/T-antigen (FCT) region pilin genes, nga-ifs-
slo, speG, ideS, ska, sclA, fba, enn, emm, mrp, and mga (49). Collec-
tively, these findings demonstrate that the genome segments that
had been horizontally acquired and retained on the evolutionary
pathway leading from clade 1 to clade 2 strains have contributed
disproportionately to remodeling the global transcriptome, in-
cluding many virulence genes, and argue that they are likely not
selectively neutral.
The genomic changes accruing in the molecular evolution of
clade 2 to clade 3 are of considerable interest because they are
associated with the emergence, dissemination, and recent rapid
increase in the frequency of emm89 invasive infections recorded in
many countries (46, 61–65). In contrast to the 11% of the gene
content reshaped by HGT in the transition from clade 1 to clade 2,
a more modest 1% was reshaped in the transition from clade 2 to
clade 3. Despite this modest 1% change we found that in compar-
ing the transcriptomes of clade 2 strain MGAS23530 with clade 3
strain MGAS26844, 4% and 11% of the genes were differentially
expressed at the exponential and stationary growth phases, respec-
tively (Fig. 7A; see also Table S3, section 2, in the supplemental
material). Genes located within regions of HGT were significantly
overrepresented among the differentially expressed genes in expo-
nential growth (P  0.0001). Included among the 28 genes with
significantly increased expression in exponential growth were the
critical virulence genes nga-ifs-slo (Fig. 7B). To confirm that in-
creased expression of nga and slo is a trait broadly common to
clade 3 strains, we assessed the expression of these genes by quan-
titative PCR (qPCR) in 11 strains selected to represent the range of
genetic and geographic diversity present in the emm89 major pop-
ulation (Fig. 7E and F). The subclades represented by these 11
isolates encompass 1,120 (94%) of the 1,193 strains of the major
emm89 population. All 5 of the clade 3 strains had significantly
greater nga and slo expression than all 6 of the clade 1 and 2 strains
(P  0.001). This is consistent with previous findings for Nga
NADase activity assessed for 27 strains of the cohort (50). Impor-
tantly, significantly increased transcription of nga-ifs-slowas asso-
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FIG 4 Distribution of SNPs and regions of horizontal gene transfer. Illustrated in
the genome atlas of clade 2 strain MGAS23530 from the 1st (outermost) ring to the
7th (innermost) ring are the following. (Ring 1) Genome size in megabase pairs
(black). (Ring 2) Landmarks: rRNA, 23S 16S-5S rRNA; FCT, fibronectin/collagen/
T-antigen; SLS, streptolysin S; SRT, streptin; SAL, salvaricin; MGA, mga operon;
HAS, hasABC capsule synthesis operon. (Rings 3 and 4) Coding sequences on the
forward (light green) and reverse (dark green) strands. (Ring 5) Clade 1 strain
MGAS11027 SNPs (n 1,915, light blue) relative to clade 2 strain MGAS23530.
(Ring 6) Clade 3 strain MGAS27061 SNPs (n 415, red) relative to clade 2 strain
MGAS23530. (Ring 7) Predicted regions of horizontal gene transfer separating
clade 1 and 2 strains (light blue), clade 2 and 3 strains (red), and clade 3 and
subclade 3D strains (dark blue) as listed in Table 1. SNPs are nonrandomly dis-
tributed. Regions of elevated SNP density correspond to predicted horizontal gene
transfer/recombination blocks.
TABLE 1 HGT recombination blocks separating GAS emm89/M89 clades
Block Clades Starta Stopa
Length
(kb) SNPs Genes M-like % ID
RB1b C1-C2 92,389 164,162 71,774 411 72 M2 88.74b
RB2 C1-C2 295,481 297,574 2,094 9 2 M2 100.00
RB3c C1-C2 773,487 780,634 7,148 55 8 M2 99.55
RB4c C1-C2 794,417 800,659 6,243 28 8 M2 99.55
RB5 C1-C2 921,261 960,297 39,037 100 41 M2 99.68
RB6 C1-C2 1,022,619 1,030,407 7,789 20 6 M2 99.97
RB7 C1-C2 1,543,651 1,561,165 17,515 103 13 M2 97.17
RB8 C1-C2 1,577,916 1,597,447 19,532 138 21 M28 99.58
RB9 C2-C3 86,603 88,366 1,764 12 2 M5/M23 99.38
RB10 C2-C3 145,163 155,569 10,407 59 11 M1/M12 98.52
RB11 C2-C3 244,407 244,758 352 5 1 M5 100.00
RB12 C2-C3 1,472,262 1,473,025 764 9 1 M12 100.00
RB13 C2-C3 1,558,898 1,559,698 801 7 2 M49 99.75
RB14 C2-C3 1,693,613 1,694,805 1,193 6 2 M5/M6 100.00
RB15 C3-SC3D 341,762 359,579 17,818 106 21 M1 99.67
a The start and stop positions provided are relative to the MGAS23530 genome.
b The first 18.6 kb and last 39.6 kb are M2-like (99% identity [ID]); however, the central 13.5 kb FCT pilus-encoding region is unlike that of any other sequenced GAS emm-type.
c RB3 and RB4 likely represent a single HGT event that encompasses the intervening streptin lantibiotic synthesis genes, thus resulting in a larger single recombination of 26,697 bp.
Beres et al.
6 ® mbio.asm.org May/June 2016 Volume 7 Issue 3 e00403-16
 
m
bio.asm
.org
 o
n
 August 8, 2017 - Published by 
m
bio.asm
.org
D
ow
nloaded from
 
ciated with the emergence and epidemic increase in S. pyogenes
emm1 invasive infections (32, 34, 35).
Additional genetic changes that differentiate epidemic clade 3
strains from the most recent predecessor clade 2 strains are acqui-
sition of phage 27061.1 encoding speC and spd1 and loss of the
hasABC capsule synthesis genes. To explore the role these genetic
changes have potentially played in contributing to the emergence
of the epidemic clade 3 strains, we inspected transcript data for the
speC and spd1 genes and hasABC virulence factor genes between
the preepidemic (clade 1 and clade 2) and epidemic (clade 3)
emm89 representative strains. Transcript levels of speC and spd1
were significantly greater for the preepidemic clade 1 MGAS11027
strain than for the epidemic clade 3 MGAS26844 strain at both
phases of growth assessed (Fig. 7C). The finding of significantly
lower levels of speC and spd1 transcripts in the genetically repre-
sentative epidemic clade 3 strain further argues that presence of
these virulence factors in the clade 3 lineage is unlikely to have
conferred a fitness advantage relative to clade 1 strains and there-
fore is an unlikely mechanism for the emergence of the epidemic
clone and displacement of the predecessor clade 1 and clade 2
strains (46). Similarly, although the epidemic clade 3 strains are
incapable of producing the antiphagocytic hyaluronic acid (HA)
capsule due to HGT-mediated loss of the hasABC genes, the tran-
script data indicate that this gene loss was likely not responsible for
a significant decrease in capsule production between the clade 2
and 3 strains. We found that transcription of hasABC was very
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FIG 5 Prophage content of the emm89 strains. Shown is the phylogeny inferred by neighbor-joining for the 1,193 clade 1, 2, and 3 isolates based on 8,989 core
SNPs filtered to exclude SNPs acquired by horizontal gene transfer events. Isolates are colored by phage genotype (PG) as indicated in the index. PGs were
assigned in order of prevalence of occurrence in the strain sample. With the exception of PG02 (absence of phage), most of the PGs are exclusive to a single clade.
PG01 was first present in the strain sample in 2003 in two isolates, one each of clades 2 and 3. The year 2003 is also when epidemic clade 3 strains were first present
in the strain sample.
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weak in clade 2 strain MGAS23530 under both growth conditions
assessed (Fig. 7D), arguing that capsule production was already
negligible before the HGT-mediated loss of the hasABC genes by
the clade 3 lineage. Capsule production was strong only for clade 1
strain MGAS11027 at the exponential growth phase.
We next investigated the molecular basis for the differences in
capsule production using all strains of clades 1 and 2. Sequence
variation in the hasABC promoter has been reported to alter tran-
scription and capsule production (66). Inspection of the genome
sequence data, coupled with Sanger sequencing of the hasABC
promoter for all clade 1 and 2 strains, identified two major vari-
ants (see Fig. S6A in the supplemental material). These promoter
variants corresponded to strong clade 1 strain MGAS11027 and
weak clade 2 strain MGAS23530 hasABC transcription. Whereas
the two promoter variants are equally represented among clade 1
strains, the vast majority (88.5%) of clade 2 strains had the weak
transcription variant (see Fig. S6B and C in the supplemental ma-
terial). Expression of hasA correlated perfectly with the promoter
variant (Fig. 7G), which is consistent with results of HA produc-
tion assays previously reported for 27 strains of the cohort (50).
Importantly, hasA transcript levels for strains with the weak pro-
moter variant were not significantly different from those of the
clade 3 strains that lack the hasABC genes. Thus, the evolution of
clade 3 from a clade 2 progenitor strain likely involved a transition
from very little capsule production to no capsule production. This
again argues that loss of the hasABC genes by the clade 3 lineage is
unlikely to confer a fitness advantage relative to the clade 1 and 2
strains and is therefore an unlikely mechanism for the epidemic
emergence and displacement of the predecessor lineages. Whereas
some S. pyogenes outbreaks have been associated with strains hav-
ing a hyperencapsulation phenotype (33, 67) we are unaware of a
body of epidemiological data associating GAS epidemic outbreaks
with a loss of capsule phenotype. To summarize, the global tran-
scriptome data comparing the preepidemic and epidemic strains
show that neither production of phage-encoded virulence factors
SpeC and Spd1 nor lack of production of the antiphagocytic HA
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capsule is a characteristic unique to the emergent clade 3 strains
relative to the predecessor clade 1 and 2 strains and therefore does
not correspond to the epidemic increase in invasive infections.
The very recent emergence of SC-3D strains is temporally as-
sociated with a single HGT event in which SC-3D strains acquired
an 18 kb sequence that includes 21 genes, including genes encod-
ing the secreted virulence proteins SpyA, a C3-like ADP-
ribosyltransferase, and SpeJ, a pyrogenic exotoxin superantigen
(49, 51–53). On the basis of the nearly identical sequences, this 18
kb region likely was acquired from an epidemic emm1 clone do-
nor. Differentially expressed genes accounted for 2% and 11% of
the genome at the exponential and stationary growth phases, re-
spectively, in comparisons of the transcriptomes of strain
MGAS26844 (clade 3) and MGAS27520 (SC-3D) (Fig. 7A; see also
Table S3, section 3, in the supplemental material). This was the
lowest number of differentially expressed genes among the four
genetically representative strains studied, consistent with SC-3D
strains being a recently emerged closely genetically related subset
of the epidemic clade 3 strains.
Further transcriptome remodeling and epidemic perpetua-
tion. Discovery of significant alteration of transcriptomes caused
by HGT events, and the role in emergence and dissemination of
clade 3 organisms, led us to investigate the hypothesis that addi-
tional transcriptome remodeling contributed to perpetuating the
emm89 epidemic. We tested this hypothesis by focusing on SC-3D
strains, because these organisms disproportionately increased in
frequency in Finland starting from 2013 (Fig. 2A; see also Fig. S4
and Table S1 in the supplemental material). Given the relatively
modest number of genes differentially expressed between
MGAS26844 (clade 3) and MGAS27520 (subclade 3D), we inter-
rogated the genome data for candidate polymorphisms that may
further alter the transcriptome and potentially influence pathogen
behavior. Analysis of the genome sequences of the 33 SC-3D
strains found unique single amino acid replacements in gene reg-
ulators CovR (S130N) and LiaS (K214R). These polymorphisms
were prevalent among the SC-3D strains; 11 strains had the CovR
(S130N) change, and 6 strains had the LiaS (K214R) change (see
Fig. S4). In contrast, none of the other 1,183 emm89 or 3,615
emm1 strains (32) studied had these polymorphisms. The branch-
ing of the strains with these mutations in the inferred phylogeny
and their absence in other S. pyogenes strains indicate identity by
descent rather than identity by independent mutation (i.e., com-
monality by evolutionary convergence).
Repeated recovery of clonal progeny with either the CovR
(S130N) or LiaS (K214R) polymorphisms from invasive episodes
has not been reported previously and thus was unexpected. Be-
cause relatively little is known about liaS in S. pyogenes, we elected
to study the LiaS (K214R) polymorphism in more detail. Consis-
tent with our altered-transcriptome hypothesis, RNAseq analysis
showed that the transcriptome of strain MGAS27710 LiaS
(K214R) differed from that of SC-3D LiaS wild-type strain
MGAS27520, including significant changes in expression of sev-
eral virulence genes (data not presented). However, as these two
strains are not isogenic, the extent to which the altered transcrip-
tion was due to the LiaS (K214R) polymorphism could not be
assessed. To address this issue, we constructed a LiaS (K214R)
isogenic mutant from parental strain MGAS27556 and conducted
RNAseq analysis. We found that, compared to the wild-type pa-
rental strain, the LiaS (K214R) isogenic mutant had 127 and 70
differentially expressed genes in exponential-phase growth and
stationary-phase growth, respectively (see Table S3, section 4, in
the supplemental material). Virulence genes significantly in-
creased in expression by the LiaS (K214R) isogenic mutant in-
cluded all 9 genes of the streptolysin S biosynthesis operon
(sagABCDEFGHI) in exponential phase and speG encoding strep-
tococcal pyrogenic exotoxin G in stationary phase.
The capacity of the CovR (S130N) and LiaS (K214R) naturally
occurring mutant strains to repeatedly cause serious infections
means that they can effectively spread between hosts and implies
that they are not attenuated in the ability to survive in the upper
respiratory tract, the more common S. pyogenes niche. Consistent
with this idea, we found that the naturally occurring mutant
strains had an enhanced ability to survive in human saliva ex vivo
relative to SC-3D wild-type strain MGAS27520 (Fig. 8H). These
results contrast with data showing that strains with other covR or
covS (covR/S) mutations have reduced survival in human saliva
relative to wild-type strains (68).
Comparative strain virulence. The epidemiological, compar-
ative genomic, and transcriptome data demonstrate that clade 1,
2, and 3 organisms are genotypically and phenotypically distinct
and strongly suggest differences in virulence. To test this hypoth-
esis, the three genetically distinct reference strains for each clade
were compared in mouse and nonhuman primate models of ne-
crotizing fasciitis (NF) (69–71). Epidemic clade 3 reference strain
MGAS26844 was significantly more lethal and caused significantly
greater tissue damage in the mouse NF infection model than the
two preepidemic reference strains (Fig. 8A and B). Moreover, rel-
ative to clade 1 reference strain MGAS11027, epidemic clade 3
strain MGAS26844 caused significantly larger lesions with greater
tissue damage in a nonhuman primate model of NF (Fig. 8C to E).
Concluding comment. We have used S. pyogenes as a model
pathogen for studying the evolutionary genomics of epidemic dis-
ease and the molecular basis of bacterial pathogenesis. The organ-
ism is a strict human pathogen, causes abundant infections world-
wide, and has a relatively small genome (~1.8 Mb). In addition to
its propensity to cause epidemic waves, the availability of compre-
hensive, population-based strain collections from many coun-
tries, coupled with the fact that humans are its only natural host,
means that the history of underlying events that generate genomic
diversity is not obscured by molecular processes occurring in non-
human hosts or environmental reservoirs. These factors afford
considerable advantages in the use of S. pyogenes as a model system
compared to many other pathogenic bacteria such as E. coli, S.
enterica, and S. aureus.
The primary goal of our study was to determine if genomic
changes linked with the origin and perpetuation of human epi-
demic disease have remodeled global gene expression and altered
virulence in the model pathogen S. pyogenes. We were especially
interested in determining the effect, if any, of horizontally ac-
quired genome segments on global gene expression and virulence
of the progeny strains. Despite the importance of bacterial patho-
gens in human and veterinary health, remarkably few studies have
addressed how transcriptome remodeling contributes to the ori-
gin and perpetuation of epidemics. Zhou et al. (26) studied diver-
sity in 149 genomes of S. enterica serovar Paratyphi A and used the
resulting data to speculate that most recent increases in frequen-
cies of bacterial diseases are due to environmental changes rather
than to the novel evolution of pathogenic bacteria. In essence, it
was suggested that many epidemics and pandemics of bacterial
disease in humans did not involve recent evolution of particularly
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virulent organisms but instead reflected chance environmental
events. A similar conclusion was reached in studies of other patho-
gens, for example, Yersinia pestis, S. enterica serovar Agona, My-
cobacterium tuberculosis, Mycobacterium leprae, and Shigella son-
nei (17, 25). Although this may be the case for some pathogens, on
the basis of the full-genome data from 4,815 strains, human pa-
tient information (33), analysis of isogenic mutant strains,
RNAseq studies, and experimental animal infection, we arrive at a
fundamentally different conclusion for emm89 and emm1 S. pyo-
genes, organisms that have caused epidemics involving tens of mil-
lions of human infections in the last 30 years. In particular, our
results unambiguously show that newly emerged clones causing
epidemic disease are more virulent than previously circulating
precursor organisms. For clarity, we consider all steps in
pathogen-host interaction to potentially contribute to the viru-
lence phenotype, including survival and proliferation after initial
contact with the host through invasion of deeper tissues and
spread to new hosts. Conclusions about molecular pathogenesis
and virulence based solely or predominantly on population
genomic analyses of a convenience sample of strains and resulting
inferences are not likely to fully reflect the biology of pathogen and
host interaction. This issue may be especially problematic if only
one or a few nucleotide changes significantly alter virulence.
We believe that our findings have important implications for
bacterial pathogens that must successfully circumvent host de-
fenses, at both the individual level and the population level. Our
analysis demonstrated that, among the various emm89 clades and
subclades, considerable variation exists among global transcrip-
tomes, in both the spectrum of genes expressed and their magni-
tude of expression. This means that, in essence, many different
antigen, toxin, and virulence factor profiles can be and are being
displayed to host populations as a function of individual strain
genotype and not necessarily of emm-type. In the absence of one
or a small number of conserved antigens mediating protective
immunity, regardless of the microbe, significant variations in an-
tigen repertoire have implications for vaccine research, formula-
tion, and deployment.
Many elegant studies of the population genomics of bacterial
pathogens have been published over the last decade (4, 5, 10–18,
23, 25, 26, 32, 72–76). There is a small but emerging literature
bearing on the impact of regulatory plasticity in bacterial evolu-
tion and fitness (77–81). However, there has been very little work
designed to integrate microbial population genomics, molecular
pathogenesis processes, microbial emergence, transcriptome re-
modeling, and virulence. Our findings suggest that this could be a
fruitful area of research for other microbial pathogens. The result-
ing data are likely to have significant implications for understand-
ing bacterial epidemics and for translational research efforts to
blunt their detrimental effects.
MATERIALS AND METHODS
Further details of the materials and methods used are described in
Text S1 in the supplemental material.
Bacterial strains. We studied 1,200 GAS emm89 strains, including
1,198 strains causing invasive infections and two from pharyngitis pa-
tients (see Table S1 in the supplemental material). The vast majority of the
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the preepidemic strain at the distal margin (G) showing greater dissemination.P values for panels B, D, E, F, and G were determined with the Mann-Whitney test.
(H) Viability of naturally occurring variant strains MGAS28980 CovR (S130N) and MGAS27552 LiaS (K214R) in human saliva persisted for 2 and 4 weeks longer,
respectively, than that of wild-type strain MGAS27520. No growth,10 CFU/ml for a 1:10 dilution. IM, intramuscularly; NHP, nonhuman primate.
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strains (n  1,178) were collected as part of comprehensive population-
based public health surveillance of GAS invasive infections conducted in
the United States, Finland, and Iceland between 1995 and 2014. The re-
maining emm89 strains were recovered from invasive disease cases in
Ontario, Canada, and from a pharyngitis case in Italy. A subset of this
population has been previously studied, and preliminary genetic findings
have been presented (35, 48).
Genome sequencing. Isolation of chromosomal DNA, generation of
paired-end libraries, and multiplexed sequencing were accomplished as
described previously (32, 35) using Illumina (San Diego, CA) instruments
(HiSeq2500, MiSeq, and NextSeq). Whole-genome sequencing data for
the 1,200 isolates studied were deposited in the NCBI Sequence Read
Archive.
Reference genome assembly, annotation, and polymorphism dis-
covery. The bioinformatics tools used for assembling and annotating the
reference genomes and for identifying and analyzing polymorphisms in
the population studied are described in Text S1 in the supplemental ma-
terial. Complete genome sequences for genetically representative strains
MGAS11027, MGAS23530, and MGAS27061 were deposited in the NCBI
GenBank database. MGAS11027, MGAS23530, and MGAS27061 were
deposited in the BEIR strain repository.
Phylogenetic inference and population structure. The bioinformat-
ics tools used for sequence alignments, detection, and filtering of HGT
polymorphisms, for clustering and phylogenetic inference, and for anal-
ysis of the population structure are described in Text S1 in the supplemen-
tal material.
Gene content andmobile genetic element analysis. The known GAS
pangenome core and accessory gene content was determined based on 30
complete genomes of 18 different emm-types (see Table S2 in the supple-
mental material) as described in Text S1 in the supplemental material.
Among the 53,336 coding sequences (CDSs) of the 30 genomes, PanOCT
identified 3,338 ortholog clusters, culled by BLAST reciprocal-best-hit
analysis to 2,835 on the basis of the criterion of no two clusters sharing
95% amino acid identity. A GAS pseudo-pangenome sequence of ~3
Mbp was generated by concatenating onto the emm89 MGAS23530 ref-
erence genome all accessory gene content not already present in the ge-
nome, starting with emm89 strains MGAS11027 and MGAS27061, and
then the remaining 27 genomes by emm-type (i.e., emm1, emm2, emm3,
etc.). Based on mapping of the emm89 reference genome sequencing reads
to the GAS-30 pangenome, an RPKM (reads per kilobase of transcript per
million reads mapped) value of 50 corresponded to gene presence. A
phage was called present if a minimum of 80% of its gene content repre-
sented in the GAS-30 pangenome was found to be present. Reads not
mapping to the GAS-30 pangenome were assembled de novo using
SPAdes. Resultant contigs with greater than 100 nucleotides were queried
against the NCBI nonredundant database using BLAST to determine their
nature.
Construction of isogenic mutant strains. The construction of the
liaS isogenic mutant strain was accomplished by allelic exchange as
previously described (35). Briefly, MGAS27556 LiaS (K214R) was gen-
erated by introducing the liaS A641G SNP into wild-type strain
MGAS27556, using DNA amplified from strain MGAS27552, a clinical
isolate with a naturally occurring liaS A641G SNP (i.e., LiaS K214R
substitution) as the template. Successful introduction of the desired
SNP and the absence of spontaneous spurious mutations were con-
firmed in candidate isogenic mutants by whole-genome sequencing.
Primers, plasmids, and restriction enzymes used in the construction
are listed in Text S1 in the supplemental material.
Transcriptome sequencing and expression analysis .Whole-genome
transcriptional analysis was conducted for strains genetically representa-
tive of the clades and subclades studied using RNAseq as previously de-
scribed (35, 82) with minor modifications. Briefly, RNA was isolated from
triplicate cultures grown in Todd-Hewitt broth supplemented with yeast
extract (THY). Multiplexed libraries were subjected to single-end se-
quence analysis (50 bp) to a high depth value (~10 million reads/sample)
with an Illumina HiSeq2500 instrument. RNAseq reads were mapped to
the genome of the most closely related emm89 reference strain (for exam-
ple, clade 3 strains were mapped to the genome of reference strain
MGAS27061). Use of multiple reference sequences was critical, as the use
of a single common reference did not permit accurate quantitative read
mapping to the divergent sequences in the regions of HGT. RNAseq data
were normalized, and genes statistically differently expressed following
Benjamini-Hochberg correction at a minimum 1.5-fold change in mean
transcript level were identified using the bioinformatics tools provided in
Text S1 in the supplemental material. RNAseq transcriptome data were
deposited in the NCBI Gene Expression Omnibus database. Expression
levels of the key virulence genes nga, slo, and hasA were assessed by quan-
titative real-time PCR in triplicate for 11 strains genetically representative
of the most abundant subclades of the major population using primers,
probes, and protocols previously described (50). The significance of
strain-to-strain differences in expression was assessed by one-way analysis
of variance (ANOVA).
Experimental animal infections. The virulence of serotype emm89
reference strains MGAS11027, MGAS23530, and MGAS26844 was as-
sessed using mouse and nonhuman primate models of necrotizing fascii-
tis (32, 69–71). These strains have a wild-type (i.e., the most commonly
occurring) allele for all major transcription regulators, including covR/S,
ropB, andmga. All animal experiments were approved by the Institutional
Animal Care and Use Committee of Houston Methodist Research Insti-
tute.
Accession numbers. Whole-genome sequencing data for the 1,200
isolates studied were deposited in the NCBI Sequence Read Archive under
accession number SRP059971. Complete genome sequences for geneti-
cally representative strains MGAS11027, MGAS23530, and MGAS27061
were deposited in the NCBI GenBank database under accession numbers
CP013838, CP013839, and CP013840, respectively. MGAS11027,
MGAS23530, and MGAS27061 were deposited in the BEIR strain repos-
itory under accession numbers NR-33707, NR-33706, and NR-50285,
respectively. RNAseq transcriptome data were deposited in the NCBI
Gene Expression Omnibus database under accession number GSE76816.
SUPPLEMENTAL MATERIAL
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